From fertilisation to implantation in mammalian pregnancy- modulation of early human reproduction by the endocannabinoid system

Pharmaceuticals

Volumn 3, Issue 9, 2010, Pages 2910-2929

  Bambang, Katerina N ^a   Karasu, Tulay ^a   Gebeh, Alpha ^a   Taylor, Anthony H ^a   Marczylo, Timothy H ^a   Lam, Patricia ^a   Willets, Jonathon M ^a   Konje, Justin C ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Endocannabinoid; Fertilization; Implantation; Reproduction

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; ANANDAMIDE; CALCIUM ION; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID; FATTY ACID AMIDASE; FATTY ACID BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE C; POTASSIUM ION; SODIUM ION;

BLASTOCYST; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME SYNTHESIS; FERTILIZATION; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOMODULATION; NATURAL KILLER CELL; NEUROTRANSMISSION; NIDATION; NONHUMAN; OOCYTE DEVELOPMENT; OVIDUCT; PERINATAL DRUG EXPOSURE; PREGNANCY; PREGNANCY OUTCOME; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; SPERMATOGENESIS; SPERMATOZOON MOTILITY; TH1 CELL; TH2 CELL;

EID: 77957259631     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3092910     Document Type: Review

References (134)

1. Park, B.; McPartland, J.M.; Glass, M. Cannabis, cannabinoids and reproduction. Prostaglandins Leukot. Essent. Fatty Acids 2004, 70, 189-197.
2. Evers, J.L. Female subfertility. Lancet 2002, 360, 151-159.
3. Regan, L.; Braude, P.R.; Trembath, P.L. Influence of past reproductive performance on risk of spontaneous abortion. BMJ 1989, 299, 541-545.
4. Wenger, T.; Croix, D.; Tramu, G.; Leonardelli, J. Effects of delta-9-tetrahydrocannabinol on pregnancy, puberty, and the neuroendocrine system. In Marijuana/Cannabinoids: Neurobiology and Neurophysiology; Murphy, L., Bartke, A., Eds.; CRC Press: Boca Raton, FL USA, 1992.
5. Schuel, H.; Burkman, L.J.; Lippes, J.; Crickard, K.; Mahony, M.C.; Giuffrida, A.; Picone, R.P.; Makriyannis, A. Evidence that anandamide-signaling regulates human sperm functions required for fertilization. Mol. Reprod. Devel. 2002, 63, 376-387.
6. Abel, E.L. Infertility increases when alcohol and marijuana are combined. Teratology 1985, 31, 35-40.
7. Devane, W.A.; Dysarz, F.A.; Johnson, M.R.; Melvin, L.S.; Howlett, A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 1988, 34, 605-613.
8. Munro, S.; Thomas, K.L.; Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365, 61-65.
9. Devane, W.A.; Hanus, L.; Breuer, A.; Pertwee, R.G.; Stevenson, L.A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258, 1946-1949.
10. Mechoulam, R.; Ben-Shabat, S.; Hanus, L.; Ligumsky, M.; Kaminski, N.E.; Schatz, A.R.; Gopher, A.; Almog, S.; Martin, B.R.; Compton, D.R.; et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 1995, 50, 83-90.
11. Wenger, T.; Fragkakis, G.; Giannikou, P.; Probonas, K.; Yiannikakis, N. Effects of anandamide on gestation in pregnant rats. Life Sci. 1997, 60, 2361-2371.
12. Pandey, R.; Mousawy, K.; Nagarkatti, M.; Nagarkatti, P. Endocannabinoids and immune regulation. Pharmacol. Res. 2009, 60, 85-92.
13. Rodriguez de Fonseca, F.; Del Arco, I.; Bermudez-Silva, F.J.; Bilbao, A.; Cippitelli, A.; Navarro, M. The endocannabinoid system: Physiology and pharmacology. Alcohol 2005, 40, 2-14.
14. Di Marzo, V.; Petrosino, S. Endocannabinoids and their levels in health and disease. Curr. Opin. Lipid 2007, 18, 129-140.
15. Sipe, J.C.; Scott, T.M.; Murray, S.; Harismendy, O.; Simon, G.M.; Cravatt, B.F.; Waalen, J. Biomarkers of Endocannabinoid System Activation in Severe Obesity. PLoS One 2010, 5, e8792.
16. Dalle Carbonare, M.; Del Giudice, E.; Stecca, A.; Colavito, D.; Fabris, M.; D'Arrigo, A.; Bernardini, D.; Dam, M.; Leon, A. A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: A neglected story. J. Neuroendocrinol. 2008, 20, 26-34.
17. Rodriguez de Fonseca, F.; Navarro, M.; Gomez, R.; Escuredo, L.; Nava, F.; Fu, J.; Murillo- Rodriguez, E.; Giuffrida, A.; LoVerme, J.; Gaetani, S.; et al. An anorexic lipid mediator regulated by feeding. Nature. 2001, 414, 209-212.
18. Lambert, D.M.; Vandevoorde, S.; Jonsson, K.O.; Fowler, C.J. The palmitoylethanolamide family: A new class of anti-inflammatory agents? Curr. Med. Chem. 2002, 9, 663-674.
19. Di Marzo, V.; Fontana, A.; Cadas, H.; Schinelli, S.; Cimino, G.; Schwartz, J.C.; Piomelli, D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372, 686-691.
20. Schmid, H.H. Pathways and mechanisms of N-acylethanolamine biosynthesis: Can anandamide be generated selectively? Chem. Phys. Lipids 2000, 108, 71-87.
21. Okamoto, Y.; Morishita, J.; Tsuboi, K.; Tonai, T.; Ueda, N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 2004, 279, 5298-5305.
22. Jin, X.H.; Uyama, T.; Wang, J.; Okamoto, Y.; Tonai, T.; Ueda, N. cDNA cloning and characterization of human and mouse ca(2+)-independent phosphatidylethanolamine N-acyltransferases. Biochim. Biophys. Acta. 2009, 1791, 32-38.
23. Yamano, Y.; Asano, A.; Ohyama, K.; Ohta, M.; Nishio, R.; Morishima, I. Expression of the haras suppressor family member 5 gene in the maturing rat testis. Biosci. Biotechnol. Biochem.2008, 72, 1360-1363.
24. Wang, J.; Okamoto, Y.; Morishita, J.; Tsuboi, K.; Miyatake, A.; Ueda, N. Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-beta-lactamase family. J. Biol. Chem. 2006, 281, 12325-31235.
25. Ueda, N.; Liu, Q.; Yamanaka, K. Marked activation of the N-acylphosphatidylethanolaminehydrolyzing phosphodiesterase by divalent cations. Biochim. Biophys. Acta 2001, 1532, 121-127.
26. Leung, D.; Saghatelian, A.; Simon, G.M.; Cravatt, B.F. Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 2006, 45, 4720-4726.
27. Liu, J.; Wang, L.; Harvey-White, J.; Huang, B.X.; Kim, H.Y.; Luquet, S.; Palmiter, R.D.; Krystal, G.; Rai, R.; Mahadena, A.; et al. Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology. 2008, 54, 1-7.
28. Bisogno, T.; Howell, F.; Williams, G.; Minassi, A.; Cascio, M.G.; Ligresti, A.; Matias, I.; Schiano-Moriello, A.; Paul, P.; Williams, E.J.; et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signalling in the brain. J. Cell Biol. 2003, 163, 463-468.
29. Muccioli, G.G. Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discov. Today 2010, 15, 474-483.
30. Mechoulam, R.; Deutsch, D.G. Toward an anandamide transporter. Proc. Natl. Acad. Sci. USA 2005, 102, 17541-17542.
31. Kaczocha, M.; Glaser, S.T.; Deutsch, D.G. Identification of intracellular carriers for the endocannabinoid anandamide. Proc. Natl. Acad. Sci. USA 2009, 106, 6475-6380.
32. Furuhashi, M.; Hotamisligil, G.S. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Rev. 2008, 7,489-503.
33. Gong, Y.Z.; Everett, E.T.; Schwartz, D.A.; Norris, J.S.; Wilson, F.A. Molecular cloning, tissue distribution, and expression of a 14-kDa bile acid-binding protein from rat ileal cytosol. Proc. Natl. Acad. Sci. USA 1994, 91, 4741-4745.
34. Chmurzynska, A. The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism. J. Appl. Genet. 2006, 47, 39-48.
35. Larqué, E.; Krauss-Etschmann, S.; Campoy, C.; Hartl, D.; Linde, J.; Klingler, M.; Demmelmair, H.; Caño, A.; Gil, A.; Bondy B.; Koletzko, B. Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins. Am. J. Clin. Nutr. 2006, 84, 853-861.
36. Nixon, B.; MacIntyre, D.A.; Mitchell, L.A.; Gibbs, G.M.; O'Bryan, M.; Aitken, R.J. The identification of mouse sperm-specific-associated proteins and characterization of their ability to act as decapacitation factors. Biol. Reprod. 2006, 74, 275-287.
37. Yamamoto, T.; Yamamoto, A.; Watanabe, M.; Matsuo T.; Yamazaki, N. Kataoka, M.; Terada, H.; Shinohara, Y. Classification of FABP isoforms and tissues based on quantitative evaluation of transcript levels of these isoforms in various rat tissues. Biotechnol. Lett. 2009, 31, 1695-1701.
38. Tsuboi, K.; Sun, Y.X.; Okamoto, Y.; Araki, N.; Tonai, T.; Ueda, N. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J. Biol. Chem. 2005, 280, 1082-1092.
39. Wei, B.Q.; Mikkelsen, T.S.; McKinney, M.K.; Lander, E.S.; Cravatt, B.F. A second fatty acid amide hydrolase with variable distribution among placental mammals. J. Biol. Chem. 2006, 281, 36569-36578.
40. Dinh, T.P.; Kathuria, S.; Piomelli, D. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol. Pharmacol. 2004, 66, 1260-1264.
41. Blankman, J.L.; Simon, G.M.; Cravatt, B.F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 2007, 14, 1347-1356.
42. Pan, B.; Wang, W.; Long, J.Z.; Sun, D.; Hillard, C.J.; Cravatt, B.F.; Liu, Q.S. Blockade of 2- arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4- (dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) enhances retrograde endocannabinoid signalling. J. Pharmacol. Exp. Ther. 2009, 331, 591-597.
43. Habayeb, O.M.H.; Bell, S.C.; Konje, J.C. Endogenous Cannabinoids: Metabolism and their role in reproduction. Life Sci. 2002, 70, 1963-1977.
44. Matsuda, L.A.; Lolait, S.J.; Brownstein, M.J.; Young, A.C.; Bonner, T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346, 561-564.
45. Idris, A.I.; van Hof, R.J.; Greig, I.R.; Ridge, S.A.; Baker, D.; Ross, R.A.; Ralston, S.H. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat. Med. 2005, 11, 774-779.
46. Pierantoni, R.; Cobellis, G.; Meccariello, R.; Cacciola, G.; Chianese, R.; Chioccarelli, T.; Fasano, S. Cb1 activity in male reproduction: Mammalian and non-mammalian animal models. Vit. Horm. 2009, 81, 367-387.
47. Maccarrone, M. Endocannabinoids and reproductive endocrinology. Curr. Opin. Investig. Drugs. 2009, 10, 305-310.
48. Howlett, A.C.; Barth, F.; Bonner, T.I.; Cabral, G.; Casellas, P.; Devane, W.A.; Felder, C.C.; Herkenham, M.; Mackie, K.; Martin, B.R.; et al. International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002, 54, 161-202.
49. Taylor, A.H.; Abbas, M.S.; Habiba, M.A. Konje, J.C. Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle. Histochem. Cell Biol. 2010, 133, 557-565.
50. Kim, H.I.; Kim, T.H.; Shin, Y.K.; Lee, C.S.; Park, M.; Song, J.H. Anandamide suppression of Na+ currents in rat dorsal root ganglion neurons. Brain Res. 2005, 1062, 39-47.
51. Maingret, F.; Patel, A.J.; Lazdunski, M.; Honore, E. The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. EMBO J. 2001, 20, 47-54.
52. Godlewski, G.; Offertaler, L.; Wagner, J.A.; Kunos, G. Receptors for acylethanolamides-GPR55 and GPR119. Prostaglandins Other Lipid Mediat. 2009, 89, 105-111.
53. Overton, H.A.; Babbs, A.J.; Doel, S.M.; Fyfe, M.C.; Gardner, L.S.; Griffin, G.; Jackson, H.C.; Procter, M.J.; Rasamison, C.M.; Tang-Christiensen, M.; et al. De-orphanization of a G proteincoupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 2006, 3, 167-175.
54. O'Sullivan, S.E. Cannabinoids go nuclear: Evidence for activation of peroxisome proliferatoractivated receptors. Br. J. Pharmacol. 2007, 152, 576-582.
55. Guzeloglu-Kayisli, O.; Kayisli, U.A.; Taylor, H.S. The role of growth factors and cytokines during implantation: endocrine and paracrine interactions. Semin Reprod Med 2009, 27, 62-79.
56. Toth, A.; Blumberg, P.M.; Boczan, J. Anandamide and the vanilloid receptor (TRPV1). Vit.Horm. 2009, 81, 389-419.
57. Alger, B.E. Retrograde signalling in the regulation of synaptic transmission: focus on endocannabinoids. Prog. Neurobiol. 2002, 68, 247-286.
58. Buznikov, G.A.; Nikitina, L.A.; Bezuglov, V.V.; Francisco, M.E.Y.; Bohsen, G.; Obispo-Peak, I.N.; Peterson, R.E, Weiss, E.R.; Schuel, H.; Temple, B.R.S.; Morrow, A.L.; Lauder, J.M. A putative 'pre-nervous' endocannabinoid system in early Echinoderm development. Dev. Neurosci. 2010, 32, 1-18.
59. Battista, N.; Pasquariello, N.; Di Tommaso, M.; Maccarrone, M. Interplay between endocannabinoids, steroids and cytokines in the control of human reproduction. J. Neuroendocrinol. 2008, 20, 82-89.
60. Taylor, A.H.; Ang, C.; Bell, S.C.; Konje, J.C. The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy. Hum. Reprod. Update 2007, 13, 501-513.
61. Schuel, H. Tuning the oviduct to the anandamide tone. J. Clin. Invest. 2006, 116, 2087-2090.
62. Wang, H.; Guo, Y.; Wang, D.; Kingsley, P.J.; Marnett, L.J.; Das, S.K.; Dubois, R.N.; Dey, S.K. Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat. Med. 2004, 10, 1074-1080.
63. Sun, X.; Dey, S.K. Aspects of endocannabinoid signaling in periimplantation biology. Mol. Cell Endocrinol. 2008, 286, S3-S11.
64. Paria, B.C.; Ma, W.; Andrenyak, D.M.; Schmid, P.C.; Schmid, H.H.; Moody, D.E.; Deng, H.; Makriyannis, A.; Dey, S.K. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. Biol. Reprod. 1998, 58, 1490-1495.
65. Paria, B.C.; Das, S.K.; Dey, S.K. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proc. Natl. Acad. Sci. USA 1995, 92, 9460-9464.
66. Taylor, A.H.; Amoako, A.A.; Bambang, K.; Karasu, T.; Gebeh, A.; Lam, P.M.; Marzcylo, T.H.M.; Konje, J.C. Endocannabinoids and pregnancy. Clin. Chim. Acta 2010, 411, 921-930.
67. El-Talatini, M.R.; Taylor, A.H.; Elson, J.C.; Brown, L.; Davidson, A.C.; Konje, J.C. Localisation and function of the endocannabinoid system in the human ovary. PLoS One 2009, 4, e4579.
68. Barrett, K.E.; Ganong, W.F. Ganong's Review of Medical Physiology, 23rd ed.; McGraw-Hill Medical: New York, NY, USA, 2009; p. 714.
69. Chabbert Buffet, N.; Djakoure, C.; Maitre, S.C.; Bouchard, P. Regulation of the human menstrual cycle. Front Neuroendocrinol. 1998, 19, 151-186.
70. El-Talatini, M.R.; Taylor, A.H.; Konje, J.C. The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle. Fertil. Steril. 2010, 93, 1989-1996.
71. El-Talatini, M.R.; Taylor, A.H.; Konje, J.C. Fluctuation in anandamide levels from ovulation to early pregnancy in in-vitro fertilization-embryo transfer women, and its hormonal regulation. Hum. Reprod. 2009, 24, 1989-1998.
72. Carreau, S.; Silandre, D.; Bois, C.; Bouraima, H.; Galeraud-Denis, I.; Delalande, C. Estrogens: a new player in spermatogenesis. Folia Histochem. Cytobiol. 2007, 45, S5-S10.
73. Sofikitis, N.; Giotitsas, N.; Tsounapi, P.; Baltogiannis, D.; Giannakis, D.; Pardalidis, N. Hormonal regulation of spermatogenesis and spermiogenesis. J. Steroid. Biochem. Mol. Biol. 2008, 109, 323-330.
74. Sriraman, V.; Rao, A.J. FSH, the neglected sibling: evidence for its role in regulation of spermatogenesis and Leydig cell function. Indian J. Exp. Biol. 2005, 43, 993-1000.
75. Schuel, H.; Burkman, L.J.; Lippes, J.; Crickard, K.; Mahony, M.C.; Giuffrida, A.; Picone, R.P.; Makriyannis, A. Evidence that anandamide-signaling regulates human sperm functions required for fertilization. Mol. Reprod. Dev. 2002, 63, 376-387.
76. Maccarrone, M.; Cecconi, S.; Rossi, G.; Battista, N.; Pauselli, R.; Finazzi-Agro, A. Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells. Endocrinology 2003, 144, 20-28.
77. Rossi, G.; Gasperi, V.; Paro, R.; Barsacchi, D.; Cecconi, S.; Maccarrone, M. Follicle-stimulating hormone activates fatty acid amide hydrolase by protein kinase A and aromatase-dependent pathways in mouse primary Sertoli cells. Endocrinology 2007, 148, 1431-1439.
78. Grimaldi, P.; Orlando, P.; Di Siena, S.; Lolicato, F.; Petrosino, S.; Bisogno, T. Geremia, R.; De Petrocellis, L.; Di Marzo, V. The endocannabinoid system and pivotal role of the CB2 receptor in mouse spermatogenesis. Proc. Natl. Acad. Sci. USA 2009, 106, 11131-11136.
79. Gervasi, M.G.; Rapanelli, M.; Ribeiro, M.L.; Farina, M.; Billi, S.; Franchi, A.M.; Martinez, S. P. The endocannabinoid system in bull sperm and bovine oviductal epithelium: role of anandamide in sperm-oviduct interaction. Reproduction 2009, 137,403-414.
80. Grimaldi, P.; Rossi, G.; Catanzaro, G, Maccarrone, M. Modulation of the endocannabinoid enzyme fatty acid amide hydrolase by follicle-stimulating hormone. Vit. Horm. 2009, 81, 231-261.
81. Aquila, S.; Guido, C.; Santoro, A.; Perrotta, I.; Laezza, C.; Bifulco, M.; Sebastiano, A. Anat. Rec. 2010, 293, 298-309.
82. Aquila, S.; Guido, C.; Santoro, A.; Gazzerro, P.; Laezza, C.; Baffa, M.F.; Ando, S.; Bifulco, M. Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human sperm. Br. J. Pharamacol. 2010, 159, 831-841.
83. Aquila S.; Guido, C.; Laezza, C.; Santoro, A.; Pezzi, V.; Panza, S.; Ando, S.; Bifulco, M. A new role of anandamide in human sperm: Focus on metabolism. J. Cell Physiol. 2009, 221, 147-153.
84. Cobellis, G.; Ricci, G.; Cacciola, G.; Orlando, P.; Petrosino, S.; Cascio, M.G.; Bisogno, T.; De Petrocellis, L.; Chioccarelli, T.; Altucci, L.; Fasano, S.; Meccariello, R.; Pierantoni, R.; Ledent, C.; Di Marzo, V. A gradient of 2-arachonoylglycerol regulates mouse epididymal sperm start-up. Biol. Reprod. 2010, 82, 451-458.
85. Maccarrone, M.; Barboni, B.; Paradisi, A.; Bernabo, N.; Gasperi, V.; Pistilli, M.G.; Fezza, F.; Lucidi, P.; Mattioli, M. Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capactitation and acrosome reaction. J. Cell Sci. 2005, 118, 4393-4404
86. Francavilla, F.; Barbonetti, A.; Vassallo, M.R.; Rapino, C.; Antonangelo, C.; Pasquariello, N.; Catanzaro, G.; Barboni, B.; Maccarrone, M. Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability. Endocrinology 2009, 150, 4692-4700.
87. Rossato, M.; Ion Popa, F.; Ferigo, M.; Clari, G.; Foresta, C. Human sperm express cannabinoid receptor CB1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. J. Clin. Endocrinol. Metab. 2005, 90, 984-991.
88. Wang, H.; Xie, H.; Guo, Y.; Zhang, H.; Takahashi, T.; Kingsley, P.J.; Marnett, L.J.; Das, S.K.; Cravatt, B.F.; Dey, S.K. Fatty acid amide hydrolase deficiency limits early pregnancy events. J. Clin. Invest. 2006, 116, 2122-2131.
89. Schuel, H.; Burkman, L.J. A tale of two cells: Endocannabinoid-signaling regulates functions of neurons and sperm. Biol. Reprod. 2005, 73, 1078-1086.
90. Meizel, S. The sperm, a neuron with a tail:'neuronal' receptors in mammalian sperm. Biol. Rev. 2004, 79, 713-732.
91. Bray, C.; Son, J.-H.; Meizel, S. A nicotinic acetylcholine receptor is involved in the acrosome reaction of human sperm initiated by recombinant human ZP3. Biol. Reprod. 2002, 67, 782-788.
92. Bray, C.; Son, J.-H.; Kumar, P.; Harris, J.D.; Meizel, S. A role for the human sperm glycine receptor/Cl- channel in the acrosome reaction initiated by recombinant human ZP3. Biol. Reprod. 2002, 66, 91-97.
93. Wang, H.; Matsumoto, H.; Guo, Y.; Paria, B.C.; Roberts, R.L.; Dey, S.K. Differential G proteincoupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. Proc. Natl. Acad. Sci. USA 2003, 100, 14914-14919.
94. Paria, B.C.; Song, H.; Wang, X.; Schmid, P.C.; Krebsbach, R.J.; Schmid, H.H.; Bonner, T.I.; Zimmer, A.; Dey, S.K. Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J. Biol. Chem. 2001, 276, 20523-20528.
95. Maccarrone, M.; DeFelici, M.; Klinger, F.G.; Battista, N.; Fezza, F.; Dainese, E.; Siracusa, G.; Finazzi-Agro, A. Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus. Mol. Hum. Reprod. 2004, 10, 215-221.
96. Lazzarin, N.; Valensise, H.; Bari, M.; Ubaldi, F.; Battista, N.; Finazzi-Agro, A, Maccarrone, M. Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle. Gynecol. Endocrinol. 2004, 18, 212-218.
97. Horne, A.W.; Phillips, J.A., 3rd, Kane, N.; Lourenco, P.C.; McDonald, S.E.; Williams, A.R.; Simon, C.; Dey, S.K.; Critchley, H.O. CB1 expression is attenuated in Fallopian tube and decidua of women with ectopic pregnancy. PLoS One 2008, 3, e3969.
98. Maccarrone, M. Endocannabinoids: Friends and foes of reproduction. Prog. Lipid Res. 2009, 48, 344-354.
99. Battista, N.; Bari, M.; Rapino, C.; Trasatti, F.; D'Agostino, A.; Maccarrone, M. Regulation of female fertility by the endocannabinoid system. Hum. Fertil. 2007, 10, 207-216.
100. Wang, H.; Xie, H.; Sun, X.; Kingsley, P.J.; Marnett, L.J.; Cravatt, B.F.; Dey, S.K. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. Prostaglandins Other Lipid Mediat. 2007, 83, 62-74.
101. Paria, B.C.; Lim, H.; Wang, X.N.; Liehr, J.; Das, S.K.; Dey, S.K. Coordination of differential effects of primary estrogen and catecholestrogen on two distinct targets mediates embryo implantation in the mouse. Endocrinology 1998, 139, 5235-5246.
102. Guo, Y.; Wang, H.; Okamoto, Y.; Ueda, N.; Kingsley, P.J.; Marnett, L.J.; Schmid, H.H, Das, S.K.; Dey, S.K. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J. Biol. Chem. 2005, 280, 23429-23432.
103. Schmid, P.C.; Paria, B.C.; Krebsbach, R.J.; Schmid, H.H.; Dey, S.K. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc. Natl. Acad. Sci. USA 1997, 94, 4188-4192.
104. Maccarrone, M.; DeFelici, M.; Klinger, F.G.; Battista, N.; Fezza, F.; Dainese, E.; Siracusa, G.; Finazzi-Agro, A. Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus. Mol. Hum. Reprod. 2004, 10, 215-221.
105. Wang, J.; Paria, B.C.; Dey, S.K.; Armant DR. Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development. Biol. Reprod. 1999, 60, 839-844.
106. Yang, Z.M.; Paria, B.C.; Dey, S.K. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development. Biol. Reprod. 1996, 55, 756-761.
107. Turco, M.Y.; Matsukawa, K.; Czernik, M.; Gasperi, V.; Battista, N.; Della Salda, L.; Scapolo, P.A.; Loi, P.; Maccarrone, M.; Ptak, G. High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation. Hum. Reprod. 2008, 23, 2331-2338.
108. Paria, B.C.; Dey, S.K. Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation. Chem. Phys Lipids 2000,108, 211-220.
109. Wang, H.; Dey, S.K. Roadmap to embryo implantation: clues from mouse models. Nat. Rev. Genet. 2006, 7, 185-199.
110. Geber, W.F.; Schramm, L.C. Effect of marihuana extract on fetal hamsters and rabbits. Toxicol. Appl. Pharmacol. 1969, 14, 276-282.
111. Maccarrone, M.; Valensise, H.; Bari, M.; Lazzarin, N.; Romanini, C.; Finazzi-Agro, A. Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility. J. Immun. 2001, 166, 7183-7189.
112. Maccarrone, M.; Bari, M.; Di Rienzo, M.; Finazzi-Agro, A.; Rossi, A. Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor Ikaros. Evidence for a synergistic effect of leptin. J. Biol. Chem. 2003, 278, 32726-32732.
113. Maccarrone, M.; Bisogno, T.; Valensise, H.; Lazzarin, N.; Fezza, F.; Manna, C.; Di Marzo, V.; Finazzi-Agro, A. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol. Hum. Reprod. 2002, 8, 188-195.
114. Habayeb, O.M.; Taylor, A.H.; Finney, M.; Evans, M.D.; Konje, J.C. Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. JAMA 2008, 299, 1135-1136.
115. Maccarrone, M.; Valensise, H.; Bari, M.; Lazzarin, N.; Romanini, C.; Finazzi-Agro, A. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet 2000, 355, 1326-1329.
116. Trabucco, E.; Acone, G.; Marenna, A.; Pierantoni, R.; Cacciola, G.; Chioccarelli, T.; Mackie, K.; Fasano, S.; Colacurci, N.; Meccariello, R. Endocannabinoid system in first trimester placenta: low FAAH and high CB1 expression characterize spontaneous miscarriage. Placenta 2009, 30, 516-522.
117. Habayeb, O.M.; Taylor, A.H.; Bell, S.C.; Taylor, D.J.; Konje, J.C. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. Endocrinology 2008, 149, 5052-5060.
118. Helliwell, R.J.; Chamley, L.W.; Blake-Palmer, K.; Mitchell, M.D.; Wu, J.; Kearn, C.S.; Glass, M. Characterization of the endocannabinoid system in early human pregnancy. J. Clin. Endocrinol. Metab. 2004, 89, 5168-5174.
119. Maccarrone, M.; Finazzi-Agro, A. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ. 2003, 10, 946-955.
120. Habayeb, O.M.; Taylor, A.H.; Evans, M.D.; Cooke, M.S.; Taylor, D.J.; Bell, S.C.; Konje, J.C. Plasma levels of the endocannabinoid anandamide in women-a potential role in pregnancy maintenance and labor? J. Clin. Endocrinol. Metab. 2004, 89, 5482-5487.
121. Fonseca, B. M.; Correia-da-Silva, G.; Taylor, A. H.; Lam, P. M. W.; Marczylo, T. H.; Konje, J. C.; Bell, S. C.; Teixeira, N. A. N-Acylethanolamine levels and expression of their metabolizing enzymes during pregnancy. Endocrinology 2010, 151, 3965-3974.
122. Piccini, M. P. T-Cell Cytokines in Pregnancy Am. J. Reprod. Immunol. 2002, 47, 289-294.
123. Piccini, M.P.; Beloni, L.; Livi, C.; Maggi, E.; Scarselli, G.; Romagnani, S. Defective production of both leukaemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat. Med. 1998, 4, 1020-1024.
124. Tapia, A.; Salamonsen, L.A.; Manuelpillai, U.; Dimitriadis, E. Leukaemia inhibitory factor promotes human first trimester extravillous trophoblast adhesion to extracellular matrix and secretion of tissue inhibitor metalloproteinases-1 and -2. Hum. Reprod. 2008, 23, 1724-1732.
125. Pestonjamasp, V.K.; Burstein, S.H. Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. Biochim. Biophys. Acta 1998, 1394, 249-260.
126. Bisogno, T.; Maurelli, S.; Melck, D.; De Petrocellis, L.; Di Marzo, V. Biosynthesis, uptake and degradation of anandamide and palmitoylethanolamide in leukocytes. J. Biol. Chem. 1997, 272, 3315-3323.
127. Di Marzo, V.; De Petrocellis, L.; Sepe, N.; Buono, A. Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells. Biochem. J. 1996, 316, 977-984.
128. Smith, S.R.; Terminelli, C.; Denhardt, G. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. J. Pharm. Exp. Ther. 2000, 293, 136-150.
129. Newton, C.A.; Klein, T.W.; Friedman, H. Secondary immunity to Legionella Pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect. Immun. 1994, 62, 4015-4020.
130. Maccarrone, M.; De Petrocellis, L.; Bari, M.; Fezza, F.; Salvati, S.; Di Marzo, V.; Finazzi-Agro, A. Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes. Arch. Biochem. Biophys. 2001, 393, 321-328.
131. Ross, R.A.; Brockie, H.C.; Pertwee, R.G. Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide. Eur. J. Pharm. 2000, 81, 715-723.
132. Ravinet Trillou, C.; Arnone, M.; Delgorge, C.; Gonalons, N.; Keane, P.; Maffrand, J.P.; Soubrie, P. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet induced obese mice. Am. J. Physiol. 2003, 284, 345-353.
133. Arnone, M.; Maruani, J.; Chaperon, F.; Thiebot, M.H.; Poncelet, M.; Soubrie, P.; Le Fur, G. Selective inhibition of sucrose and ethanol intake by SR141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 1997, 132, 104-106.
134. Simiand, J.; Keane, M.; Keane, P.E.; Soubrie, P. SR141716 a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav. Pharmacol. 1998, 9, 179-181.